Company Filing History:
Years Active: 2007-2020
Title: David Souza: Innovator in Gene Therapy
Introduction
David Souza is a prominent inventor based in Waltham, MA (US). He has made significant contributions to the field of gene therapy, particularly in the production of adeno-associated vectors. With a total of 2 patents, his work has advanced the understanding and application of viral vectors in medical treatments.
Latest Patents
David Souza's latest patents include innovative methods for producing oversized adeno-associated virus (AAV) particles. These methods allow for the creation of AAV particles containing oversized recombinant AAV genomes, which are crucial for various therapeutic applications. Additionally, he has developed novel combinations of liver-specific enhancers and promoter elements aimed at achieving persistent transgene expression in the liver. This invention involves the use of adenoviral vectors and other viral vectors to deliver therapeutic genes effectively.
Career Highlights
David Souza is currently employed at Genzyme Corporation, where he continues to push the boundaries of gene therapy research. His work has been instrumental in developing new techniques that enhance the efficacy of gene delivery systems. His contributions have not only advanced scientific knowledge but also hold the potential for significant clinical applications.
Collaborations
David has collaborated with notable colleagues, including Donna Armentano and Samuel C Wadsworth. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of gene therapy.
Conclusion
David Souza's work exemplifies the spirit of innovation in the biotechnology sector. His patents and research efforts are paving the way for new treatments that could transform patient care.